Trusted Resources: Education
Scientific literature and patient education texts
Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis
source: Radiology
year: 2018
authors: Wan K, Sun J, Yang D, Liu H, Wang J, Cheng W, Zhang Q, Zeng Z, Zhang T, Greiser A, Jolly MP, Han Y, Chen Y
summary/abstract:Purpose:
To measure left ventricular (LV) myocardial strain with cine magnetic resonance (MR) imaging and a deformable registration algorithm (DRA) and to assess the prognostic value of myocardial strain in patients with light-chain (AL) amyloidosis.
Materials and Methods:
In this prospective study, 78 consecutive patients with AL amyloidosis who underwent contrast material-enhanced cardiac MR imaging were enrolled at West China Hospital. LV myocardial strains and late gadolinium enhancement (LGE) were evaluated. Association between myocardial strain and all-cause mortality was analyzed with the stepwise Cox regression model.
Results:
Global longitudinal strain (GLS) and global circumferential strain (GCS) were significantly lower in the no or nonspecific LGE group compared with the subendocardial LGE and transmural LGE groups (mean GLS, -10% ± 3 [standard deviation] vs -7% ± 3 vs -4% ± 1; P < .001) (mean GCS, -13% ± 3 vs -11% ± 3 vs -7% ± 2; P < .001). GLS and GCS were reduced in patients without clinical cardiac amyloidosis (mean GLS, -13% ± 3 vs -16% ± 2; P = .005) (mean GCS, -16% ± 1 vs -19% ± 2; P = .02). Circumferential and radial strains were impaired in basal segments in accordance with the distribution of LGE. Multivariate Cox analysis revealed that GCS (hazard ratio [HR] = 1.16 per 1% absolute decrease; 95% confidence interval [CI]: 1.03, 1.31; P = .02) and the presence of transmural LGE (HR = 1.75; 95% CI: 1.10, 2.80; P = .02) were independent predictors of all-cause mortality after adjustment for LV ejection fraction, right ventricular ejection fraction, LV mass index, GLS, and global radial strain.
Conclusion:
Strain parameters derived with cine MR imaging-based DRA may be a new noninvasive imaging marker with which to evaluate the extent of cardiac amyloid infiltration and may offer independent prognostic information for all-cause mortality in patients with AL amyloidosis.
organization: Sichuan University, China; Siemens Healthineers Northeast Asia Collaboration, China; Siemens Healthineers, Germany; Siemens Healthineers, USA; University of Pennsylvania, USADOI: 10.1148/radiol.2018172435
read more full text
Related Content
-
Cardiac Amyloidosis Program at Brigham and Women’s HospitalThe Cardiac Amyloidosis Program at Brigh...
-
World Heart Day 2022World Heart Day is an opportunity for ...
-
Attralus Update on Amyloid Fibril Targeting for Removal by Spencer Guthrie – ASG Webinar – 9/9https://www.youtube.com/watch?v=vP4wvJq5...
-
Webinar Presentation by Heather J. Landau on Light Chain (AL) Amyloidosishttps://www.youtube.com/watch?v=hOCrAsld...
-
The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain AmyloidosisLight-chain (AL) amyloidosis is a system...
-
Mayo AL Staging and New York Heart Staging Explanation: Dr. Julie Rosenthal – ASG Webinar 7/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
Treatment Patterns and Health Care Resource Utilization Among Patients With Relapsed/Refractory Systemic Light Chain...Background: Treatment for patients with...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.